This brand name is authorized in Hong Kong
The drug MEFLUPEN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Flupentixol hydrochloride
UNII HAT84MLQ6Z - FLUPENTIXOL DIHYDROCHLORIDE
|
|
|
|
2
Melitracen
UNII J3448GKP5W - MELITRACEN HYDROCHLORIDE
|
|
Melitracen is a tricyclic antidepressant with activating properties in low doses. It has similar pharmacological properties as amitriptyline but is less sedative. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N06CA02 | Melitracen and psycholeptics | N Nervous system → N06 Psychoanaleptics → N06C Psycholeptics and psychoanaleptics in combination → N06CA Antidepressants in combination with psycholeptics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HK | Department of Health Drug Office | Identifier(s): 55630 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
